CNQ · HEAL.CN
Restart Life Sciences Corp.
CA$0.08+CA$0.02 (+23.08%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.74% below the high.
Loading market information…
CNQ · NIRV.CN · CAD
Stock price, earnings
Quote as of Jan 28, 2026, 02:04 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Nirvana Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nirvana Life Sciences Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nirvana Life Sciences Inc. specializes in the scientific investigation and creation of therapeutic offerings derived from psychedelics. Additionally, the company is engaged in pioneering methods for the isolation and purification of psychoactive compounds, as well as advancing cultivation techniques to enable large-scale growth of the relevant biological material. The organization was founded in 2020 and maintains its principal office in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.08+CA$0.02 (+23.08%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.74% below the high.
CA$0.07-CA$0.01 (-7.14%)
Ultrobotix Ltd.’s quoted price sits in the lower half of its reported 52-week range, 85.56% below the high.
$0.01$0.00 (0.0%)
ChitogenX Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Biocure Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.02+CA$0.01 (+50.0%)
Aquarius Surgical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
CA$0.01CA$0.00 (0.0%)
Albert Labs International Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.07-CA$0.12 (-63.16%)
WPD Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.78% below the high.
$0.00$0.00 (0.0%)
NanoSphere Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.94% below the high.
